Thermocore Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Venture capital arm of the Bank of Cyprus and a group of private investors provides "several" million dollars in funding for preclinical development of a thermography catheter to identify previously undetectable and high-risk areas of diseased coronary arteries. Working in cooperation with consulting firm Arthur D. Little, Thermocore will incorporate an array of sensors to map the interior of arteries on the basis of temperature variations. "Clinical data generated by an early version of such a device showed greater thermal variations in patients with unstable angina and acute myocardial infarction than in patients with normal coronary arteries," Thermocore explains in a release. The device, which would serve as a complement to angiograms, is expected to enter European trials within six to eight months and begin U.S. trials in the second half of 2002
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.